Introduction of the expert consensus statement for  definition， diagnosis and treatment of #br#
acute exacerbations of idiopathic pulmonary fibrosis using Delphi Technology

doi:10.3969/j.issn.1004-583X.2016.06.021

Clinical Focus

Previous Articles Next Articles

Introduction of the expert consensus statement for definition， diagnosis and treatment of #br# acute exacerbations of idiopathic pulmonary fibrosis using Delphi Technology

Department of Infectious Diseases，the Second Hospital of Hebei Medical University，Shijiazhuang 050000，China

Received:2016-01-28 Online:2016-06-05 Published:2016-06-06
Contact: Corresponding author:Song Ning，Email:1469713257@qq.com

Abstract

Abstract:

The evidence based medicine for clinical diagnosis and treatment of acute exacerbation of idiopathic pulmonary fibrosis (AEIPF) is insufficient. So far， there is still lack of specialized and systematic expert consensus for AEIPF clinical diagnosis and treatment. Recently， British scholars developed a consensus statement for the definition， diagnosis， and treatment of AEIPF using Delphi technique， especially put forth some advice on the support treatment， use of antimicrobial agents， immunosuppressive agents， anticoagulant，and anti fibrosis drugs， also rose step treatment， discharge planning， longterm management suggestions，et al. This paper will introduce related expert consensus， in order to provide practical reference for chinese clinicians to manage AEIPF.

Key words: lung diseases, interstitial, diagnosis；clinical protocols

Guo Xianli，Yuan Shengfang，Song Ning. Introduction of the expert consensus statement for definition， diagnosis and treatment of #br# acute exacerbations of idiopathic pulmonary fibrosis using Delphi Technology[J]. Clinical Focus, doi: 10.3969/j.issn.1004-583X.2016.06.021.

Add to citation manager EndNote|Ris|BibTeX

URL: https://huicui.hebmu.edu.cn/EN/10.3969/j.issn.1004-583X.2016.06.021

https://huicui.hebmu.edu.cn/EN/Y2016/V31/I6/673

[1]	Zhang Jiahong, Zhou Shuhong, Zhou Jing, Wang Huijuan. Clinical observation of thalidomide in treatment of connective tissue disease associated interstitial lung disease [J]. Clinical Focus, 2019, 34(7): 622-625.
[2]	Qin Qian1, 2, Yang Xiaohong1, 2, Zhou Wenjun3a, Zheng Jianxiong3a, Xiong Qin3b, Zhang Quanbo3b, Qing Yufeng3a. Analysis of clinical features and risk factors in rheumatoid arthritisrelated interstitial lung disease [J]. Clinical Focus, 2019, 34(12): 1081-1084.
[3]	Yang Qi1, Ma Ya1, Wang Bing1,2, Ming Haixia1, Gou Yunjiu2. Efficacy of Da Vinci robot and traditional videoassisted thoracic surgeryin the treatment of pulmonary diseases [J]. Clinical Focus, 2019, 34(11): 976-981.
[4]	Yuan Boyun, Liu Xin, Yuan Yadong. Part of advances in respiratory disease during 2018 [J]. Clinical Focus, 2019, 34(1): 49-55.
[5]	Song Ning，Yuan Shengfang，Jia Weihua. Major clinical progresses of infectious diseases in 2016 [J]. Clinical Focus, 2017, 32(2): 152-159.
[6]	Yuan Yadong， Shen Lixiao， Wang Li， Cao Yi. Clinical advances in respiratory diseases during 2016 [J]. Clinical Focus, 2017, 32(2): 132-138.
[7]	Pan Wensen，Yu Jing，Yuan Yadong. Endobronchial ultrasound transbronchial lung biopsy with guidesheath for diagnosis of benign peripheral pulmonary lesions [J]. Clinical Focus, 2016, 31(8): 882-885.
[8]	Li Na， Zhang Yanping. Update of diagnosis and treatment in connective tissue disease [J]. Clinical Focus, 2016, 31(5): 506-511.
[9]	He Jingjing，Qiao Yongxia， Wang Yanru，Liu Aijing. Advances in diagnosis and therapy of systemic lupus erythematosus [J]. Clinical Focus, 2016, 31(5): 475-481.
[10]	Guo Xianli,Song Ning,Liu Yue,Yuan Shengfang,Jia Weihua. Chronic pulmonary aspergillosis:rationale and clinical guidelines for diagnosis and management [J]. Clinical Focus, 2016, 31(3): 325-331.
[11]	Yuan Yadong, Chen Ye,Wang Li,Shen Lixiao. Clinical advances in pulmonary during 2015 [J]. Clinical Focus, 2016, 31(2): 143-150.
[12]	Pan Wensen， Yuan Yadong. Endoscopic diagnosis in peripheral pulmonary lesions [J]. Clinical Focus, 2016, 31(11): 1178-1183.
[13]	Yan Shu;Lu Yahua. Clinical features of pulmonary damage in ankylosing spondylitis patients and related factors [J]. Clinical Focus, 2015, 30(8): 879-882887.
[14]	. Nutritional risk screening and support therapy in elderly patients with pulmonary infection [J]. Clinical Focus, 2015, 30(7): 777-780.
[15]	Yuan Yadong;Gong Xiaowei. Clinical advances in pulmonology during 2014 [J]. Clinical Focus, 2015, 30(2): 135-141.

Introduction of the expert consensus statement for definition， diagnosis and treatment of #br# acute exacerbations of idiopathic pulmonary fibrosis using Delphi Technology

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments